LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,951,143 | +105.3% | 356,575 | +111.0% | 0.01% | +100.0% |
| Q2 2023 | $11,668,071 | +41.1% | 169,029 | -1.4% | 0.00% | +33.3% |
| Q1 2023 | $8,268,091 | +50.5% | 171,466 | +55.8% | 0.00% | +50.0% |
| Q4 2022 | $5,494,046 | +37.0% | 110,057 | +12.0% | 0.00% | 0.0% |
| Q3 2022 | $4,010,000 | -17.6% | 98,291 | +11.0% | 0.00% | 0.0% |
| Q2 2022 | $4,869,000 | +31.9% | 88,530 | -12.9% | 0.00% | +100.0% |
| Q1 2022 | $3,692,000 | -22.6% | 101,595 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $4,773,000 | +66.7% | 102,404 | +80.7% | 0.00% | 0.0% |
| Q3 2021 | $2,864,000 | +2946.8% | 56,656 | +2374.1% | 0.00% | – |
| Q2 2021 | $94,000 | +74.1% | 2,290 | +23.3% | 0.00% | – |
| Q1 2021 | $54,000 | -1.8% | 1,857 | -5.7% | 0.00% | – |
| Q4 2020 | $55,000 | +52.8% | 1,970 | +68.7% | 0.00% | – |
| Q3 2020 | $36,000 | +71.4% | 1,168 | +133.6% | 0.00% | – |
| Q2 2020 | $21,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |